BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17077652)

  • 1. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA; Yalçindag N; Atilla H; Arat M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN; Rao RD
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
    Malta JB; Soong HK; Shtein RM; Musch DC; Rhoades W; Sugar A; Mian SI
    Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE; Perry HD
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
    Russo PA; Bouchard CS; Galasso JM
    Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
    Hom MM
    Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease.
    Yoon KC; Jeong IY; Im SK; Park YG; Kim HJ; Choi J
    Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A; Rózycki R
    Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye.
    Cross WD; Lay LF; Walt JG; Kozma CM
    Manag Care Interface; 2002 Sep; 15(9):44-9. PubMed ID: 12244650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult thyroid eye disease in patients presenting with dry eye symptoms.
    Gupta A; Sadeghi PB; Akpek EK
    Am J Ophthalmol; 2009 May; 147(5):919-23. PubMed ID: 19211095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eye symptoms following cataract surgery.
    Roberts CW; Elie ER
    Insight; 2007; 32(1):14-21; quiz 22-3. PubMed ID: 17533782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of topical cyclosporine for the treatment of dry eye disease.
    Perry HD; Solomon R; Donnenfeld ED; Perry AR; Wittpenn JR; Greenman HE; Savage HE
    Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical cyclosporine a treatment in corneal refractive surgery and patients with dry eye.
    Torricelli AA; Santhiago MR; Wilson SE
    J Refract Surg; 2014 Aug; 30(8):558-64. PubMed ID: 25325897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dry eye in graft-versus-host disease].
    Fei WL; Chen JQ; Du X; Liu YH; Sun MX; Lin JX; Weng JY; Luo TZ; Yin DM; Luo XY
    Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
    Donnenfeld E; Pflugfelder SC
    Surv Ophthalmol; 2009; 54(3):321-38. PubMed ID: 19422961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.